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IN T R O D U C T IO N
There are a number of rodent models available for the study of the pathogenesis of experimental cerebral malaria. In these studies mice (Rest, 1982 In all these models an immunopathological re action is considered to be involved in the de is prevented by CD8+ T-cell depletion, but not by CD4+ T-cell depletion. In our model (P. berghei K173, C57B1 mice) Curfs et al. (1989) confirmed a role for T-cells in the development of experimental cerebral malaria since nude mice, thymectomized mice and mice treated with an anti-T-cell serum were protected against cerebral malaria.
Here, we describe the results of treatment with anti-CD4 and anti-CD8 antibodies in P. berghei ANKA-and K173-infected C57B1 mice. The results show that treatment with anti-CD4 or anti-CD8 antibodies can prevent development of experimental cerebral malaria. Moreover, even when performed velopment of the syndrome. Studies in rodent shortly before expected death, i.e. in end-stage models showed sequestration and adherence of white blood cells to the endothelial lining of post-capillary venules in the brains in association with development of petechiae (Rest, 1982; Polder et ah 1992).
In the model described by Grau et ah (1986) (P. berghei ANKA, CBA/Ca mice), CD4+ T-cells play an important role since depletion of CD4+ T~ cells prevents, and transfer of CD4+ T-cells from mice developing cerebral malaria enhances, devel opment of the cerebral syndrome. In addition, depletion of CD8+ T-cells did not prevent cerebral malaria. In mice with Murine Acquired Immuno deficiency Syndrome (MAIDS), which is character ized by abnormal functioning of CD4+ T-cells the level of protection against murine CM is significantly increased and is related to the duration of the viral infection and, hence, with the severity of CD4+ Tcell immunodeficiency (Eckwalanga et ah 1994). In
Plasmodium berghei K173 and Plasmodium berghei ANKA were maintained by weekly transfer of parasitized erythrocytes (PE) from infected into naive mice. Experimental mice were infected intra- 
Controls

Tx intact
Tx intact Tx intact Fig, 1 . Protection against cerebral malaria in thym cctom ized (Tx) versus intact mice and in relation to treatm en t w ith anti-C D 4 or anti-C D 8 mAbs 2 days before and 2 days after infection. C57B1/6J infected w ith Plasm odium berghei K173 ( T ) or with A N K A ( # ) ; C57B1/10 infected with P. berghei K173 ( ■ ) . T h e n u m b er of m ice p rotected against CM versus the total num ber of infected mice is indicated for each experim ental group. 
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Thymectomy
Thym ectom y (Tx) was performed on mice anaes thetized with chloralhydrate (4*5 % solution; 10 /¿1/g body weight). M ice were allowed to recover from surgery for a period of 2 weeks before they were used in experiments.
Statistical analysis
For statistical analysis the Student's i-test (com parison of 2 groups) and the Kruskal-W allis test (comparison of more than 2 groups) were used. P values < 0*05 were considered significant.
RESULTS
T he effect of treatment with anti-C D 4 or a n ti-C D 8 mAbs on development of experimental cerebral malaria was analysed in thymectomized and intact C57B1/6J and C57B1/10 mice infected with P. berghei A N K A or P. berghei K173 parasites. Fig. 1 shows that treatment with anti-CD4 or a n d -C D 8 mAbs protected against CM, irrespective of th y mectomy in both C57B1/6J or C57B1/10 m ice infected with either P. berghei K173 or P. berghei A N K A parasites. Parasitaemia in .control mice that died of CM was approximately 5-10% with a reduction of the haematocrit of approximately 20% . Neither th y mectomy, nor treatment with anti-C D 4 or a n ti-C D 8 mAbs significantly changed parasitaemia and haem atocrit during infection as compared to controls. All treated mice that did not die of cerebral malaria developed the same severe anaemia in the course of the infection (data not shown). Treatm ent with either an isotype-matched rat mAb or normal rat serum as a control for depletion of C D 4 + or C D 8+ Tcells by specific rat mAbs had no effect on development of CM (Table 1) and did not change parasitaemia.
T he data in Table 1 show that treatment with anti-C D 4 or anti-C D 8 mAbs 2 days before and 2 days Table 1) . The effect on body temperature of treatment with anti-CD4 or anti-CD8 mAbs 2 days before and 2 days after infection with P . berghei K \7 2 in CS7B1/6J mice was analysed in 8 independent experiments. The results of 1 representative experiment are depicted in Fig. 2 . Body temperature of untreated infected mice dramatically decreased after 9 days of infection. Anti-CD4 or anti-C D 8 -treated mice showed a limited decrease of their body temperature which stabilized. T he same effect on body tem perature was found when treatment with anti-C D 4 or anti~CD8 mAbs was given as a single treatment up to day 8 of infection (results not shown). Anti-C D 8 treatment 2 days before and 2 days after infection prevented development of CM as effective as CD4+ T-cell depletion ( Table 1 ) and no significant difference in body temperature during infection of the anti-CD4 and anti-C D 8 treated mice was found (Fig. 2) .
To determine further the latest possible moment for effective anti-CD4 or anti-C D 8 treatment in the course of infection, mice were selected with a body temperature between 35*5 and 30 °C. If left untreated such infected mice died within 24 h as shown in Fig.  2 Table 2 show that mice with such a hypothermia could be protected against fatal cerebral malaria by treatment with anti-CD4 and/or anti-CD8 antibodies, whereas chloroquine treatment could not save any of these mice. No relation could be found between body temperature at the moment of anti-T-cell treatment (30-35'5 °C) and protection against fatal cerebral malaria (data not shown). Anti-CD4 or anti-CD8 treatment of mice with a body temperature below 30 °C never prevented death. Treatment with anti-CD4+ or anti-CD8+ mAbs in mice with end-stage disease did not protect all mice from the cerebral syndrome (Table 2 ). These last two observations were probably due to petechiae that already developed before treatment (Polder et  al. 1988) .
. The results in
Depletions that prevented further development of the cerebral syndrome also resulted in a subsequent increase in body temperature (Table 2) 
. Overall in 93% (27/29) of the anti-T-cell treated mice body temperature increased within 24 h and prevented further development of the cerebral syndrome.
DISCUSSION
These studies demonstrate the importance of CD4+ and CD8+ T-cells in the pathogenesis of murine cerebral malaria (CM), and this was independent of the use of C57B1/6J or C57B1/10 mice, or infection with P . bergh ei K173 or P. berghei ANKA parasites. Thymectomized mice were used to prevent the influx of new T-cells after treatment with anti-T-cell mAbs, but no significant difference was found when data were compared to intact mice. Treatment with anti-T-cell mAbs did not completely eliminate all CD4+ or all CD8+ T-cells. Together these obser vations suggest that complete absence of CD4+ or CD8+ T-cells is not necessary to prevent devel opment of murine CM. Anti-CD4+ or anti-CD8+ Tcell treatment had no effect on parasitaemia and development of anaemia confirming the observations made by Grau e t al. (1986) Hancock e t a l. (1994) found that treatment with anti-CD4 antibodies not only depletes CD4-positive T-cells but also CD4positive mononuclear cells; however, their possible role in CM remains to be determined.
In contrast to our results Grau e t a l. (1986) found that CD8+ T-cell depletion did not prevent de velopment of CM in P. b e rg h e i ANKA-infected CBA mice. This apparent discrepancy may relate to different mouse strains used and/or a difference in the strain of P. b e rg h e i ANKA.
Anti-CD4 or anti-CD8 T-cell treatment was effective even in mice with end-stage disease (body temperature between 35*5 and 30 °C). Histological analysis of brains of mice developing the cerebral syndrome showed that white blood cells adhere to the endothelial lining (Curfs e t a l. 1989; Polder e t a l. 1992) suggesting that these CD4+ and CD8+ T-cells are involved in disturbance of the endothelial lining and thereby in the functioning of the blood-brain barrier.
Disturbance of the blood-brain barrier in mice developing CM was also observed by Thumwood e t a l, (1988) and Neill & Hunt (1992). They described leakage of Evans blue from the vasculature into brain parenchyma. In addition, P. b e rg h e i K173-infected mice with end-stage disease are sensitive to de velopment of folic acid-induced convulsions, while control mice are not. Treatment with anti-CD4+ or anti-CD8+ mAbs not only prevents CM but suc cessfully treated mice also recover from their sensitivity to folic acid-induced convulsions within 4 h after mAb treatment (C. Hermsen e t a l . 9 unpub lished observations). In human cerebral malaria convulsions are common (Waruiru e t a l. 1996), raising the question as to whether in human CM adherence of sequestered infected red blood cells and possibly the presence of leucocytes (Polder, 1989; Porta e t a l . 1993; Eling & Kremsner, 1994; Patnaik e t a L 1994; Eling & Sauerwein, 1995) are involved in excessive activation of endothelial cells and sub sequent disturbance of the function of the bloodbrain barrier.
Chloroquine treatment could not save mice in end-stage disease while anti-CD4 or anti-CD8 treatment was still effective. This may be explained by the fact that chloroquine like most other antimalarial drugs needs more than 1 day to suppress parasitaemia effectively, whereas most of the mice in end-stage disease die within 1 day.
Our data are compatible with the hypothesis that a localized inflammatory reaction involving both CD4+ and CD8+ T-cells disturbs and damages the V J endothelial lining of the blood-brain barrier eventu ally leading to petechiae. Our data suggest that both CD4+ and CD8+ T-cells are involved in stimulation of a downstream process of the development of the petechiae.
